We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
David
Linden
lindend@cardiff.ac.uk
Prof
David
Linden
lindend@cardiff.ac.uk
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Depression is the second most common illness in primary healh care and disrupts the everyday functioning of over 100 million people worldwide. Depression is a severe mood disorder that is characterised by clinical features such as anhedonia (loss of pleasure in previously enjoyable activities), cognitive and emotional impairment, psychomotor retardation, and distrubances in sleep and appetite. 20-40% of all patients do not benefit from traditional treatment methods such as psychotherapy or antidepressant medication. This project will investigate a potential new treatment method: functional magnetic resonance imaging (fMRI) based neurofeedback. In this method people undergo fMRI scanning and receive continuously updated feedback about the activity level in a certain brain area, which they then use to learn to control their own brain activity. It has previously been shown that chronic pain patients experienced considerably less pain after exercising control over a brain area involved in pain processing. In our project feedback from a region involved in positive emotion processing will be provided so that depressed patients can learn to regulate their emotional state. A pilot study of this method form our group has shown that depressed patients are both able to regulate their emotional network and experience significant improvements in mood.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Complementary Therapy;
You can take part if:
You may not be able to take part if:
Other psychiatric or physical disorders. Current substance abuse Other psychotropic medication than listed under A171 Current psychotherapy or other specific interventions, Exclusion criteria for MRI
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by Cardiff University and funded by Health and Care Research Wales .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 10901
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
